Organoid-Based Transcriptomics Indicate IFIT-Associated Immune Modulation during Cryptotanshinone Treatment in Bladder Cancer
Open accessPreprint — published as 10.1016/j.nbt.2026.05.006 · Paper page
Abstract
Bladder cancer (BC), particularly muscle-invasive and metastatic disease, remains a major clinical challenge despite recent advances in immunotherapy. In this study, we aimed to identify a promising antitumor compound from five candidate small molecules and to explore its potential roles in BC progression. Through antiproliferative screening, cryptotanshinone (CTS) was identified as the promising candidate. Using both two-dimensional BC cell lines and three-dimensional bladder tumor organoid models, we comprehensively evaluated the effects of CTS on cell proliferation, migration, apoptosis, and organoid growth. To further explore the underlying mechanisms, transcriptomic sequencing based on bladder cancer organoid models, protein-protein interaction network analysis, and public databases (TCGA-BLCA, TIMER, and TISIDB) were integrated to examine immune-related pathways and potential molecular targets associated with CTS. GeneMANIA network prediction and molecular docking analyses were subsequently performed to investigate upstream regulatory networks and the potential interactions between CTS and key components of the cGAS-STING-IFN-I-JAK-STAT signaling pathway. Integrative analyses suggested that IFIT1, IFIT2, and IFIT3 may function as immune-associated genes potentially linked to BC progression, patient prognosis, immune cell infiltration, and PD-1/PD-L1 expression. Molecular docking results suggested that CTS may interact with core regulatory proteins within the cGAS-STING-IFN-I-JAK-STAT pathway, potentially influencing IFIT transcriptional regulation. Collectively, these findings indicate that CTS exhibits measurable antitumor and immunomodulatory effects, which may be associated with modulation of the cGAS-STING-IFN-I-JAK-STAT-IFIT signaling axis, supporting its potential as a small-molecule candidate for bladder cancer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764 · see citing works
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206 · cited 1× · see citing works
“GO (Gene Ontology)[33] categorizes genes into biological processes, molecular functions, and cellular components, while KEGG[34] (Kyoto Encyclopedia of Genes and Genomes) maps genes to specific pathways.”
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412 · see citing works
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259 · cited 1× · see citing works
“GO functional and KEGG pathway enrichment analyses and visualizations were performed using the R packages clusterProfiler[35], enrichplot, and ggplot2.”
Tefas, A., & Pitas, I. (2003) · Encyclopedia of Machine Learning · doi:10.1007/978-0-387-30164-8_665 · Cited by 29,409 · see citing works
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747 · cited 1× · see citing works
“Subsequent analyses were performed in R (version 4.3.1) [30] using RStudio as the development environment.”
InfluentialAn automated method for finding molecular complexes in large protein interaction networks
Bader, G. D., & Hogue, C. W. V. (2003) · BMC Bioinformatics · doi:10.1186/1471-2105-4-2 · Cited by 6,112 · see citing works
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 2× · see citing works
“Chemokines and their receptors coordinate the trafficking and spatial organization of immune cells within tumors[59], whereas MHC molecules are involved in antigen presentation and subsequent T-cell activation, which are essential for antitumor immune responses[58, 60].”
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · cited 1× · see citing works
“Importantly, these effects were also observed in a three-dimensional bladder tumor organoid model, which captures key features relevant to the tumor microenvironment[74].”
UniProt: the Universal Protein Knowledgebase in 2025
The UniProt Consortium, Bateman, A., Martin, M.-J., Orchard, S., Magrane, M., Adesina, A., Ahmad, S., Bowler-Barnett, E. H., Bye-A-Jee, H., Carpentier, D., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae1010 · Cited by 2,537 · cited 1× · see citing works
“If unavailable, predicted structures from the AlphaFold Protein Structure Database[47, 48], linked to UniProt[49] entries, can be used (Table S1).”
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.49 · Cited by 2,196 · cited 1× · see citing works
“Chemokines and their receptors coordinate the trafficking and spatial organization of immune cells within tumors[59], whereas MHC molecules are involved in antigen presentation and subsequent T-cell activation, which are essential for antitumor immune responses[58, 60].”
Varadi, M., Bertoni, D., Magana, P., Paramval, U., Pidruchna, I., Radhakrishnan, M., Tsenkov, M., Nair, S., Mirdita, M., Yeo, J., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad1011 · Cited by 2,052 · see citing works
The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
Kwon, J., & Bakhoum, S. F. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0761 · Cited by 1,293 · see citing works
CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networks
Tang, Y., Li, M., Wang, J.-X., Pan, Y., & Wu, F.-X. (2015) · Biosyst. · doi:10.1016/j.biosystems.2014.11.005 · Cited by 1,163 · cited 1× · see citing works
“10.2), with further evaluation performed through the cytoNCA plugin[36] to assess the degree centrality (DC), betweenness centrality (BC), and closeness centrality (CC).”
InfluentialInterferon-Stimulated Genes: What Do They All Do?
Schoggins, J. W. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015756 · Cited by 1,036 · cited 1× · see citing works
“Functional annotation indicated that many of these genes belong to interferon-stimulated genes (ISGs), which are known to participate in antiviral responses and immune-related processes in cancer[63, 64].”
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Patel, V. G., Oh, W. K., & Galsky, M. D. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21631 · Cited by 1,017 · see citing works
Present yourself! by MHC class I and MHC class II molecules
Rock, K. L., Reits, E., & Neefjes, J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.010 · Cited by 814 · cited 1× · see citing works
“Chemokines and their receptors coordinate the trafficking and spatial organization of immune cells within tumors[59], whereas MHC molecules are involved in antigen presentation and subsequent T-cell activation, which are essential for antitumor immune responses[58, 60].”
Advances in bladder cancer biology and therapy
Tran, L. L., Xiao, J.-F., Agarwal, N., Duex, J. E., & Theodorescu, D. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00313-1 · Cited by 742 · cited 1× · see citing works
“Although chemotherapy and radical cystectomy continue to represent standard treatment approaches, their clinical benefits are often constrained by treatment resistance and disease relapse[71].”
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Owen, K. L., Brockwell, N. K., & Parker, B. S. (2019) · Cancers · doi:10.3390/cancers11122002 · Cited by 711 · cited 2× · see citing works
“At the mechanistic level, GeneMANIA-based network analysis, together with prior literature, supports the involvement of the cGAS–STING[78] and JAK-STAT[79] signaling pathways play important regulatory roles in the expression of IFIT family genes.”
Yeo, G. W., Holste, D., & Kreiman, G. (2008) · doi:10.1038/embor.2008.99 · Cited by 698 · cited 1×
“…originates from urothelial cells and is characterized by clinical manifestations such as hematuria and urinary abnormalities[1]; in 2022, there were approximately 614,000 new cases and 220,000 deaths worldwide, with significantly higher incidence and mortality rates in men compared to women[2].”
Interferon-stimulated genes: roles in viral pathogenesis
Schoggins, J. W. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.03.006 · Cited by 315 · cited 1× · see citing works
“Functional annotation indicated that many of these genes belong to interferon-stimulated genes (ISGs), which are known to participate in antiviral responses and immune-related processes in cancer[63, 64].”
Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function
Rengachari, S., Groiss, S., Devos, J. M., Caron, E., Grandvaux, N., & Panne, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718426115 · Cited by 91 · cited 1× · see citing works
“Their expression is primarily regulated by interferon-induced JAK-STAT [16, 17] and cGAS-STING[18, 19] signaling pathways.”
Xiang, C., Liao, Y.-L., Chen, Z., Xiao, B., Zhao, Z., Li, A., Xia, Y., Wang, P.-X., Li, H., & Xiao, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.854215 · Cited by 87 · cited 1× · see citing works
“Binding affinity thresholds ( −4.25 kcal/mol for standard binding, −5.0 kcal/mol for good binding, and −7.0 kcal/mol for strong binding) were applied based on established criteria[70].”
InfluentialThe cGAS-STING Pathway: Novel Perspectives in Liver Diseases
Xu, D., Tian, Y., Xia, Q., & Ke, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682736 · Cited by 82 · cited 1× · see citing works
“Previous studies[65-69] have demonstrated that cyclic GMP–AMP synthase (cGAS) detects aberrant cytoplasmic double-stranded DNA arising from viral infection, pathogenic invasion, or genomic instability in tumor cells, thereby activating the STING1–TBK1–IRF3/7 signaling cascade and inducing type I…”
Choi, E., Park, C., Hwang, H.-J., Hong, S., Kim, G.-Y., Cho, E.-J., Kim, W.-J., & Choi, Y.-H. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3606 · Cited by 71 · cited 1× · see citing works
“1A), including baicalein (BCA)[52], puerarin (PUE)[53], betulinic acid (BA)[54], tanshinone IIA (Tan-IIA)[55], and cryptotanshinone (CTS)[14], all of which have been reported to exhibit anti-bladder cancer activity — on bladder cancer cell lines 5637 and T24 in vitro.”
Patient-Derived Organoids as a Model for Cancer Drug Discovery
Rae, C. J., Amato, F., & Braconi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073483 · Cited by 68 · cited 1× · see citing works
“Organoids also support personalized treatment by predicting patient-specific drug responses, helping to identify the most effective therapies and streamline drug discovery[12].”
Regulation of cGAS‐Mediated Immune Responses and Immunotherapy
Saeed, A. F. U. H., Ruan, X., Guan, H., Su, J., & Ouyang, S. (2020) · Advanced Science · doi:10.1002/advs.201902599 · Cited by 58 · cited 1× · see citing works
“Their expression is primarily regulated by interferon-induced JAK-STAT [16, 17] and cGAS-STING[18, 19] signaling pathways.”
Liu, Y.-D., Lin, F., Chen, Y.-D., Wang, R., Liu, J.-N., Jin, Y., & An, R.-H. (2020) · Journal of Cancer · doi:10.7150/jca.31422 · Cited by 47 · cited 2× · see citing works
“Previous studies have demonstrated that CTS promotes apoptosis in bladder cancer cells via the PTEN/PI3K/AKT signaling pathway[14] 4 and suppresses tumor cell invasiveness through modulation of the mTOR/β-catenin/N-cadherin axis[15].”
Advances in surgical management of muscle invasive bladder cancer
Kukreja, J., & Shah, J. (2017) · Indian Journal of Urology · doi:10.4103/0970-1591.203416 · Cited by 14 · see citing works
Flagged first, then by citations
31 of the 61 references couldn’t be matched to a known paper.
- Authors
- Yang, M., Li, R., Dong, Y., Zhou, M., Zhao, J., Liu, M., & Tan, R.
- Affiliations
- Chengdu University of Traditional Chinese Medicine (CN)
- University of Electronic Science and Technology of China (CN)
- Sichuan Academy of Traditional Chinese Medicine (CN)
- National Center for Nanoscience and Technology (CN)
- Brigham and Women's Hospital (US)
- Corresponding author
- Zhao, Junning
- Liu, Miao
- Tan, Ruirong
- ORCID
- Liu, Miao
- Venue
- New Biotechnology
- Publisher
- openRxiv
- Published
- 2026-01-29
- Volume
- 94
- Pages
- 66-82
- ISSN
- 1871-6784 (ISSN-L)
- OpenAlex
- W7161157154
- Cited by
- 0
- References
- 61
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- New Biotechnology (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82204695)
- Topics
- Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- cryptotanshinone, bladder cancer, IFIT1, IFIT2, IFIT3, interferon-stimulated genes, interferon signaling, TBK1 phosphorylation, STAT1 phosphorylation, immunomodulation, PD-1/PD-L1, small molecule anticancer agents, tumor immune infiltration, apoptosis
- MeSH terms
- Urinary Bladder Neoplasms, Cell Movement, Humans, Phenanthrenes, Gene Expression Regulation, Neoplastic, RNA-Binding Proteins, Apoptosis, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Cell Proliferation, Apoptosis Regulatory Proteins, Transcriptome, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review